Research Areas
- Integrative molecular mechanisms of cancer development and progression
- Identifying novel diagnostic and prognostic biomarkers for cancer
- Molecular environmental toxicology
- Multi-omics
Scientific Achievements
- Identified a novel fetal-onco protein, carcinoembryonic antigen-related cell adhesion molecule 7 (CEACAM7), which is expressed only in pancreatic cancer, especially in the early stages
- Investigated additional biomarkers, including MUC13 and TRIP13, in pancreatic and other gastrointestinal cancers
- Published several research articles using an integrative biology approach combining bioinformatics and molecular biology in cancer biology, environmental toxicology, and nanobiotechnology
Funding
RCMI Funding
- U54MD019970, NIH/NIMHD: Pilot Project Principal Investigator, “Investigation of Synergistic Impact of Environmental Toxicant and High Fat Diet in Hepatocellular Carcinoma (HCC)”
Scientific Advance
The Rio Grande Valley (RGV), which has a predominantly Hispanic population, experiences high rates of obesity, diabetes, and liver diseases that can increase the risk of liver cancer. Environmental factors, such as arsenic contamination in drinking water, together with unhealthy dietary habits like high-fat diets, may contribute to these health outcomes. This project will examine liver tissue samples and use advanced cell models to better understand how these environmental and lifestyle factors affect liver health at the molecular level. By identifying potential links between arsenic exposure, diet, and liver disease progression, the study aims to uncover early signs of liver damage and cancer risk. The findings could support public health efforts to improve water safety, promote healthier lifestyles, and encourage earlier screening for liver disease and liver cancer in the RGV community.
